Cannabis data analytics firm Headset Inc. has agreed to pay $1,012,876 to resolve allegations regarding the improper receipt of federal pandemic relief funds. The settlement addresses claims that the company was ineligible for a Small Business Administration Paycheck Protection Program loan obtained in 2021.
Federal relief programs under the CARES Act explicitly excluded businesses deriving revenue from plant-touching cannabis operations or ancillary services that conflicted with federal drug laws at the time. The investigation gained momentum following a False Claims Act whistleblower suit initiated by competitor Sidesolve LLC in May 2024. While Headset operates strictly as a software and market intelligence provider rather than a plant-touching enterprise, federal scrutiny regarding pandemic-era funding remains high across the sector.
This enforcement action highlights the ongoing legal risks cannabis-adjacent companies face when interacting with federal financial programs. Businesses operating in the cannabis ecosystem must maintain rigorous compliance protocols regarding federal funding opportunities, as past participation in emergency relief loans continues to face retroactive scrutiny from the Department of Justice.